Clinical Trial Update September/October 2026
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.
Clinical Scorecard: Clinical Trial Update September/October 2026
At a Glance
| Category | Detail |
|---|
| Condition | Age-related Macular Degeneration (AMD) |
| Key Mechanisms | Various interventions including dietary, pharmacological, and surgical approaches. |
| Target Population | Patients with AMD, Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO), and Uveitis. |
| Care Setting | Clinical trial settings |
Key Highlights
- Multiple studies on the efficacy and safety of new treatments for AMD.
- Focus on geographic atrophy secondary to AMD in several trials.
- Inclusion of dietary interventions and pharmacological treatments in ongoing studies.
Guideline-Based Recommendations
Diagnosis
- Utilize clinical trials to assess new diagnostic tools and treatment efficacy.
Management
- Consider participation in clinical trials for access to novel therapies.
Monitoring & Follow-up
- Regular follow-up assessments in clinical trial participants.
Risks
- Potential adverse effects associated with new treatments in clinical trials.
Patient & Prescribing Data
Individuals diagnosed with AMD, DME, RVO, and uveitis.
Emerging therapies include topical solutions, intravitreal injections, and dietary modifications.
Clinical Best Practices
- Encourage patient participation in clinical trials for cutting-edge treatment options.
- Monitor patient outcomes closely in trial settings.
Related Resources & Content
